Innovations in Screening Tools for Barrett’s Esophagus and Esophageal Adenocarcinoma

Matthew G. Bell, Prasad G. Iyer

Research output: Contribution to journalReview articlepeer-review


Purpose of Review: Esophageal adenocarcinoma (EAC) is a lethal disease with rapidly rising incidence. Screening for EAC and its metaplastic precursor, Barrett’s esophagus (BE), followed by endoscopic surveillance and endoscopic treatment of dysplasia or early EAC are promising approaches to decreasing EAC incidence and EAC mortality. Historically, screening for EAC has been completed with a traditional per-oral esophagogastroduodenoscopy (EGD); however, this method has limitations including cost, tolerability, and accessibility. For this reason, much effort has been put forward to develop more effective, minimally invasive, and accessible BE and EAC screening tools. The purpose of this review is to describe recent developments of these novel tools. Recent Findings: While endoscopic alternatives such as transnasal endoscopy are cheaper and well tolerated, they have not gained acceptance. Non-endoscopic modalities namely, swallowable cell collection devices coupled with biomarker analysis have been found to have excellent performance characteristics, tolerability, and cost effectiveness. Summary: In this article, we provide an update on innovative developments in EAC/BE screening modalities including transnasal endoscopy, capsule endomicroscopy, swallowable cell collection devices, and exhaled volatile organic compound analyses.

Original languageEnglish (US)
Article number22
JournalCurrent gastroenterology reports
Issue number12
StatePublished - Dec 2021


  • Barrett’s Esophagus
  • Esophageal Adenocarcinoma
  • Screening

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Innovations in Screening Tools for Barrett’s Esophagus and Esophageal Adenocarcinoma'. Together they form a unique fingerprint.

Cite this